On April 18, supported by the People’s Daily Health Client and sponsored by Jinsan Biotech, the “Ergothioneine IIT Clinical Research Results Conference for Eye and Liver Fields and Ergothioneine Academic and Application Exchange” was held. Over the past year, two human clinical studies focused on eye health and liver health were conducted.
Dr. Jiang Jiang, President and Chief Physician of the West District of Hefei First People’s Hospital and Standing Committee Member of the Visual Rehabilitation Specialty Committee of Anhui Rehabilitation Medical Association, shared the clinical report on ergothioneine eye wash improving ocular discomfort. He noted, “Clinical trials have found that ergothioneine has better stability than other water-soluble antioxidants, is more easily absorbed by the human body, and helps protect the eyes from oxidative damage.”
In addition, ergothioneine was found to protect mitochondria and DNA, promoting the repair and regeneration of liver cells. Ms. Shao Feng, General Manager of Anhui Linka Medical Technology Co., Ltd. and Vice President of the Food and Medicine Homology Branch of the China Anti-Aging Promotion Association, presented the clinical report on ergothioneine capsules improving liver function. She introduced that the clinical trial was initiated at Qingdao Central Hospital and demonstrated that ergothioneine reduces liver inflammation by inhibiting inflammatory pathways such as NF-κB activation. (Source: ChinaDaily)
Sign Up to Receive China Updates Weekly Newsletter for FREE, HERE
Visit HPA-China’s Information Hub, HERE